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Abstract
Background: High fat diet-induced hyperglycemia and palmitate-stimulated apoptosis was prevented by specific inhibition
of protein kinase C delta (PKCd)i nb-cells. To understand the role of PKCd in more detail the impact of changes in PKCd
activity on proliferation and survival of insulin-secreting cells was analyzed under stress-free conditions.
Methodology and Principal Findings: Using genetic and pharmacological approaches, the effect of reduced and increased
PKCd activity on proliferation, apoptosis and cell cycle regulation of insulin secreting cells was examined. Proteins were
analyzed by Western blotting and by confocal laser scanning microscopy. Increased expression of wild type PKCd (PKCdWT)
significantly stimulated proliferation of INS-1E cells with concomitant reduced expression and cytosolic retraction of the cell
cycle inhibitor p21
Cip1/WAF1. This nuclear extrusion was mediated by PKCd-dependent phosphorylation of p21
Cip1/WAF1 at
Ser146. In kinase dead PKCd (PKCdKN) overexpressing cells and after inhibition of endogenous PKCd activity by rottlerin or
RNA interference phosphorylation of p21
Cip1/WAF1 was reduced, which favored its nuclear accumulation and apoptotic cell
death of INS-1E cells. Human and mouse islet cells express p21
Cip1/WAF1 with strong nuclear accumulation, while in islet cells
of PKCdWT transgenic mice the inhibitor resides cytosolic.
Conclusions and Significance: These observations disclose PKCd as negative regulator of p21
Cip1/WAF1, which facilitates
proliferation of insulin secreting cells under stress-free conditions and suggest that additional stress-induced changes push
PKCd into its known pro-apoptotic role.
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Introduction
Sufficient b-cell mass is required for adequate insulin secretion.
Consequently, an elevated demand of insulin is controlled by
increased proliferation of pancreatic endocrine cells while
insufficient insulin secretion and the development of type-2
diabetes have been associated with b-cell death [1]. A variety of
molecular changes are involved in b-cell failure including reduced
insulin/IGF-1 receptor signaling, endoplasmic reticulum stress
and mitochondrial dysfunction [2–10]. These changes are
triggered by obesity-linked factors, such as oxidative stress,
saturated free fatty acids, cytokines and interleukins. Previous
observations from our and other groups suggested that protein
kinase C delta (PKCd) plays a decisive role in b-cell failure induced
by cytokines and free fatty acids [11–15]. Thus, mice with targeted
overexpression of a kinase-negative PKCd (PKCdKN) mutant in
b-cells are protected against high fat diet-induced glucose
intolerance and show increased survival of islet b-cells [14].
Conversely, we have previously shown that exposure of b-cells to
high concentrations of palmitate promotes PKCd-mediated
nuclear accumulation of FOXO1, a pro-apoptotic transcription
factor activated under stress conditions [14]. Furthermore, PKCd
has been found to mediate iNOS mRNA stabilization induced by
IL-1b, whereas ablation of PKCd protected mice against
streptozotozin-induced hyperglycemia [11,12]. Thus, under cer-
tain stress conditions, PKCd promotes signaling pathways leading
to apoptotic b-cell death.
Very few studies have investigated the role of PKCd for normal
b-cell function, in particular under stress-free conditions. Surpris-
ingly, mice with increased transgenic expression of PKCd in b-cells
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28828develop and age normally under chow diet and maintain normal
glucose tolerance (unpublished observations). As a matter of fact,
although PKCd can serve as a pro-apoptotic signal, depending on
the cellular context, it can also elicit anti-apoptotic and survival
signals ina varietyof cell systems[16–18].Theseproliferative effects
might involve a direct interference of PKCd with cell cycle
regulation [19,20]. Intriguingly, proliferation of differentiated b-
cells is a rare event although proteins which are important for cell
cycle progression are expressed [21]. In adult mice less than 0.4% of
b-cells stain positive for BrdU, in cultured human islet preparations
only 0.3% of the cells proliferate [21–23]. Proliferation is tightly
controlled by the sequential expression and activation of cell cycle
regulators, such as cyclins and cyclin-dependent kinases (CDKs).
The mitogenic activity of cyclin-CDK complexes is limited through
binding of transiently expressed cell cycle inhibitors [24]. Inhibitors
of the Cip/Kip family, p21
Cip1/WAF1, p27
kip1 and p57
Kip2 are
ubiquitously expressed proteins that slow down proliferation and
cell cycle progression at G1/S or G2/M phase transitions [25].
While p57
Kip2 regulates cell cycling mainly during development,
p21
Cip1/WAF1 and p27
kip1 accumulate in mitogen-starved cells and
mediatecellcyclearrestuponDNAdamage[26–28].Inaccordance
with a minor role of p21
Cip1/WAF1 during development, mice
deficientofp21
Cip1/WAF1 show normalgrowthand differentiationof
the endocrine pancreas [22]. In contrast, mice that specifically
overexpress p21
Cip1/WAF1 in b-cells have impaired b-cell replication
and develop age-related hyperglycemia due to increased apoptosis
[29].
The activity of p21
Cip1/WAF1 is regulated further by its
subcellular distribution which is controlled by phosphorylation of
p21
Cip1/WAF1 at residues located in the C-terminal domain in
proximity to the nuclear localization sequence [30]. PKB/Akt-
mediated phosphorylations at Ser146 and at Thr145 sequester
p21
Cip1/WAF1 into the cytosol [31]. In vitro phosphorylation assays
have further shown that PKCd can phosphorylate directly
p21
Cip1/WAF1 at Ser146, which triggers its cytosolic accumulation
and influences the stabilization of p21
Cip1/WAF1 [20].
In the present study, we examined the role PKCd plays in
proliferation and survival of insulin-secreting cells. Our results suggest
that PKCd phosphorylates the cell cycle inhibitor p21
Cip1/WAF1 at
Ser146, which favors its nuclear extrusion and supports proliferation
under stress-free conditions. However, under stress conditions such as
free fatty acids PKCd turns into a pro-apoptotic kinase.
Results
PKCd affects proliferation and apoptosis of
insulin-secreting cells
The first observation that PKCd may influence cell growth was
made with INS-1E cells which were transfected with either an
active PKCd (PKCdWT) or an inactive, kinase dead PKCd
(PKCdKN, Fig. 1A). Surprisingly, PKCdWT transfected cells
displayed 2.4 times more nuclei stained positive for the
proliferation marker Ki67 when compared to untransfected
control cells (Fig. 1B). The phosphorylation of PKCd at Ser643
and Thr505 was increased proportionally to the protein amount in
PKCdWT INS-1E cells under standard culture conditions, which
is indicative for an active PKCd (Fig. 1A). In PKCdKN INS-1E
cells phosphorylation of PKCd at Thr505, a phosphorylation site
of PDK1, is also increased proportionally to the protein amount,
while phosphorylation at the autophosphorylation site Ser643 is
reduced (Fig. 1A) [32–34]. It is noteworthy that the PKCdKN
mutant remains inactive regardless of the degree of phosphory-
lation. These observations suggest that PKCd supports prolifera-
tion of INS-1E cells.
PKCd controls cytosolic-nuclear trafficking of p21
Cip1/WAF1
in INS-1E cells and primary mouse islet cells
The analysis of proteins which regulate proliferation revealed that
PKCdWT cells expressed a significantly lower amount of the cell
cycle inhibitor p21
Cip1/WAF1 than control or PKCdKN INS-1E cells,
while no change in expression of p27
kip1 was apparent (Fig. 2A, B).
Notably, due to the shorter length of rodent p21
Cip1/WAF1 compared
to the human orthologue, the protein band of p21
Cip1/WAF1 displayed
an apparent molecular weight lower than 21 kDa. This band was
specific for p21
Cip1/WAF1, as a protein of the same size was detected in
bleomycin-treated wild type mouse embryonic fibroblasts (MEFs) but
not in p21
Cip1/WAF1-deficient MEFs (Fig. S1A). Moreover, the
specificity of two antibodies used in this study was confirmed by
immunocytochemistry, which revealed a p21
Cip1/WAF1-specific
staining in bleomycin-treated MEFs that was completely absent in
untreated cells or in p21
Cip1/WAF1-deficient cells exposed to the DNA
damaging agent (Fig. S1B). The reduced expression of p21
Cip1/WAF1
in PKCdWT INS-1E cells may be responsible for accelerated
proliferation.
Even more interesting is that the analysis of the subcellular
distribution of p21
Cip1/WAF1 using confocal laser scanning microsco-
py showed that PKCdWT cells expressed p21
Cip1/WAF1 almost
exclusivelyin cytoplasm.In contrast, inPKCdKNcells and toa lesser
extent in control INS-1E cells p21
Cip1/WAF1 nuclear accumulation of
Figure 1. Under non-stress condition PKCd promotes prolifer-
ation of insulin secreting INS-1E cells. (A) Representative Western
blots demonstrating expression and phosphorylation at Thr505 and at
Ser643 of PKCd of control INS-1E cells and cells overexpressing PKCdWT
or PKCdKN. Tubulin was used as loading control. Molecular weight
markers are shown on the right. (B) Percentage of control, PKCdWT and
PKCdKN INS-1E cells staining positive for Ki67 after 2 d culture. Data are
expressed as means 6 SEM of n=3–4 independent experiments.
*( p ,0.05) represents significance to control cells.
doi:10.1371/journal.pone.0028828.g001
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of p21
Cip1/WAF1 in PKCdWT cells was confirmed by Western
blotting of cytosolic and nuclear fractions (Fig. 2D). In the cytosolic
fractions the relative amount of p21
Cip1/WAF1 was similar in control
and PKCdWT cells. Furthermore, the cell cycle inhibitor remained
cytosolic in PKCdWT cells also after synchronization of cells by
serum removal (Fig. S2). Although an increased number of nuclei of
PKCdKN INS-1Ecellsstainedpositive for p21
Cip1/WAF1,theamount
of p21
Cip1/WAF1 protein detected on Western blots was not increased
relative to the amount of nuclear proteins (data not shown). These
findings do also support the hypothesis that PKCdWT cells
proliferate faster due to reduced p21
Cip1/WAF1 activity.
To transfer this finding to native b-cells, proliferation of islet cells
was examined in pancreatic slices of WT and b-cell specific
PKCdWT transgenic mice. Even after high fat feeding, Ki67
staining was not detectable neither in WT nor in PKCdWT b-cells,
which suggests that proliferation remained low (data not shown).
However, p21
Cip1/WAF1 immunoreactivity was found in nuclei of
Figure 2. Nuclear-cytosolic distribution of the cell cycle inhibitor p21
Cip1/WAF1 depends on PKCd in INS-1E cells. Representative
Western blots of (A) p21
Cip1/WAF1 and (B) p27
kip1 expression in control, PKCdWT and PKCdKN INS-1E cells and means + SEM of n=3 independent
experiments of the amounts of p21
Cip1/WAF1 and p27
kip1 relative to GAPDH as determined by densitometry. * (p,0.05) represents significance to
control INS-1E cells. (C) Subcellular distribution of p21
Cip1/WAF1 protein as analyzed by confocal laser scanning microscopy. Nuclei are stained in red,
p21
Cip1/WAF1 in green. The percentage of p21
Cip1/WAF1-positive nuclei is expressed as means + SEM of n=3–4 independent experiments. ** (p,0.01)
represents significance against control INS-1E cells. (D) Representative Western blots and relative quantities expressed as means + SEM of n=3
independent experiments of p21
Cip1/WAF1 in cytosolic and nuclear fractions of control and PKCdWT INS-1E cells. * (p,0.05) indicates significance to
p21
Cip1/WAF1 of control INS-1E cells set to 100%.
doi:10.1371/journal.pone.0028828.g002
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mice islet cells with targeted expression of PKCdWT in b-cells
showed reduced nuclear accumulation of p21
Cip1/WAF1, whereas a
prominent nuclear staining was evident in islet cells from control
mice and PKCdKN transgenic mice (Fig. 3A). These observations
suggest that PKCd-dependent regulation of p21
Cip1/WAF1 might
also influence proliferation of native b-cells.
PKCd-dependent phosphorylation of p21
Cip1/WAF1 at
Ser146 regulates its subcellular distribution and function
To investigate the molecular mechanism of PKCd-dependent
subcellular distribution of p21
Cip1/WAF1, the phosphorylation of
p21
Cip1/WAF1 at two regulatory sites was examined next. In
comparison to control INS-1E cells phoshorylation of p21
Cip1/WAF1
at Ser146 was significantly increased in PKCdWT cells, while it was
reduced in PKCdKN cells (Fig. 4A). Phosphorylation of Thr145 was
not detectable (Fig. 4B). To substantiate the effect of PKCd on
p21
Cip1/WAF1, its phosphorylation at Ser146 was examined in cells
stimulated with the phorbol myristate acetate (PMA). When cells
were starved overnight, phosphorylation at Ser146 declined (Fig. 4C,
first and second line). PMA stimulated p21
Cip1/WAF1phosphorylation
in starved cells, an effect that was completely abolished by the PKCd
inhibitor rottlerin. Inhibition of phosphorylation was accompanied by
an increase in p21
Cip1/WAF1 protein (Fig. 4C). Moreover, the effects
were specific for PKCd, as inhibition of protein kinase B or ERK1/2
neither inhibited phosphorylation at Ser146 nor promoted nuclear
accumulation of p21
Cip1/WAF1 (Fig. S3). As a matter of fact nuclear
staining of p21
Cip1/WAF1 was reduced after stimulation of PKCs with
PMA and was increased after treatment of INS-1E cellswith rottlerin
(Fig. 5). Similar but less pronounced results were obtained with
PKCdWT INS-1E cells (data not shown). Although rottlerin is a
sensitive inhibitor of PKCd, it also affects other kinases such as CaM
kinase III [35]. Therefore, we used the more specific siRNA-
approach to reduce PKCd expression and activity.
In cells transfected with siRNA against PKCd a significant
reduction of PKCd expression was accompanied by a reduced
phosphorylation at Ser146 and a concomitant increase in the
protein amount of p21
Cip1/WAF1 (Fig. 6A), an effect not found in
cells treated with control siRNA. Consistent with the results
obtained with PKCdKN cells, the knockdown of PKCd by siRNA
resulted in an increased nuclear translocation of p21
Cip1/WAF1
(Fig. 6B).
These data strongly suggest that p21
Cip1/WAF1 is a substrate of
PKCd in insulin-secreting cells. Phosphorylation of p21
Cip1/WAF1
by PKCd results in its nuclear extrusion and thereby may support
proliferation.
Functional consequences of reduced PKCd expression in
insulin-secreting cells under stress-free conditions
As PKCd supports fatty acid induced apoptosis, the effect of
changes in PKCd expression on cell death was examined in more
detail. Surprisingly, inhibition of endogenous PKCd with siRNA
or with PKCdKN mutant almost doubled the incidence of
apoptotic cell death under non-stress conditions, as revealed by
TUNEL staining (Fig. 6C and Fig. 6D). In accordance, isolated
islet cells from transgenic mice expressing PKCdKN in b-cells
displayed increased TUNEL staining when compared to control
mice (Fig. 6E). In contrast, overexpression of PKCdWT in INS-1E
cells and mice b-cells did not stimulate apoptosis under control
culture conditions (Fig. 6D and 6E). These observations suggest
that PKCd per se is not pro-apoptotic but rather promotes
proliferation.
Finally, the impact of changes in PKCd expression on cell cycle
was examined. When cells were stained for the G2/M marker
phospho-Ser10 histone H3, the same amount of control and
PKCdWT nuclei (7%), but significant more PKCdKN nuclei
(17%) stained positive for phospho-Ser10 histone H3 (Fig. S4). Cell
cycle analysis by flow cytometry of propidium iodide-stained
nuclei revealed two distinct DNA peaks (Fig. S5A). While the
major peak of control cells (58%) and significant more PKCdWT
INS-1E cells (70%) showed similar DNA staining which represents
G1 (2n chromosomes), a minor part of the cells resided in G2 (4n).
The first DNA peak of PKCdKN cells was visible at 4n (80%) and
the second peak at 8n (20%), which probably represent cells with
increased DNA content at G1 and G2, respectively. That the
DNA peaks correlate to 2n, 4n and 8n was confirmed by treatment
of the cells with colchicine (0.5 mM for 2 d) which arrests cell cycle
at G2/M transition (Fig. S5B). When DNA from freshly isolated
mouse islet cells was examined, more than 95% of WT and
PKCdKN cells stained for 2n and less than 2% of the cells for G2
(Fig. S6). The prominent peak (2n) of WT and PKCdKN islet cells
suggests that mouse islet cells are arrested in G0/G1 and that
PKCdKN expression did not affect the arrest.
Figure 3. Expression of p21
Cip1/WAF1 in mouse and human islets
and PKCd-dependent changes in cytosolic-nuclear distribution
in mouse islet cells. (A) Shown are representative pictures of
immunocytochemical staining for p21
Cip1/WAF1 in islet cells of control,
PKCdWT and PKCdKN transgenic mice. Nuclei are stained in red, p21
Cip/WAF1
in green. Note the absence of nuclear staining of p21
Cip/WAF1 in PKCdWT
mouse islet cells. (B) Immunohistochemical detection of p21
Cip/WAF1 by laser
scanning microscopy in cultured human islet cells using two distinct
antibodies from Cell Signalling (sc Ab) and BD Biosciences (BD Ab).
doi:10.1371/journal.pone.0028828.g003
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cycle inhibitor p21
Cip1/WAF1 which may influence b-cell prolifer-
ation. The mechanism which drives PKCd from a proliferative
into a pro-apoptotic role under stress conditions remains to be
elucidated.
Discussion
The present study discloses the cell cycle inhibitor p21
Cip1/WAF1
as a target of PKCd in insulin-secreting cells. Phosphorylation of
p21
Cip1/WAF1 at Ser146 by PKCd leads to its nuclear extrusion,
thereby favoring cell proliferation and survival. The fact that
p21
Cip1/WAF1 is a substrate of PKCd is consistent with a previous
report [20] and supported by our observation that both RNA
interference as well as a pharmacological inhibitor of PKCd
suppressed phosphorylation of p21
Cip1/WAF1,w h e r e a st h eP K C
activator PMA increased p21
Cip1/WAF1 phosphorylation. Further-
more, inhibition of PKCd activity by expression of a kinase-inactive
PKCd mutant reduced phosphorylation and increased nuclear
accumulation of p21
Cip1/WAF1.I nc o n t r a s t ,i nP K C dWT-expressing
cells p21
Cip1/WAF1 w a sp h o s p h o r y l a t e da tS e r 1 4 6a n dl a r g e l y
confined to the cytoplasm. Interestingly, inhibition of PKB and
ERK1/2 did not diminish phosphorylation of the cell cycle inhibitor,
indicating that PKCd is the major regulator of p21
Cip1/WAF1 in
insulin-secreting cells. Thus, our data suggest that in proliferating
insulin-secreting cells PKCd supports proliferation, at least in part, by
reducing nuclear accumulation and stability of p21
Cip1/WAF1 (Fig. 7).
In pancreatic slices of PKCdWT mice, proliferation was not
detectable. Similarly, in p21
Cip1/WAF1 KO mice, proliferation of
pancreatic islet cells was also not significantly increased (0.4% in WT
Figure 4. Phosphorylation of p21
Cip1/WAF1 depends on PKCd activity. Western blot analysis of cell lysates from control, PKCdWT and PKCdKN
INS-1E cells for p21
Cip1/WAF1 phosphorylation at (A) Ser146 and (B) Thr145. The densitometric analysis of phospho-Ser146 staining of p21
Cip1/WAF1 to
GAPDH as loading control is given as means 6 SEM of n=3 independent experiments. * (p,0.05) and ** (p,0.01) indicate significance to the
respective band of INS-1E cells set to 100%. (C) Western blots for Ser643 P-PKCd, Ser146 P-p21
Cip1/WAF1, p21
Cip1/WAF1 and tubulin as loading control of
cell lysates from INS-1E cells after 2 d control culture (Con), after serum starvation for 16 h (Ø FCS), after 90 min treatment with the PKCd inhibitor
rottlerin (10 mM) and after stimulation with PMA (1 mM for 2 min) in the presence or absence of rottlerin (10 mM for 90 min).
doi:10.1371/journal.pone.0028828.g004
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Cip1/WAF1
does not induce proliferation. Indeed, cell cycle inhibitors rather
influence the velocity of proliferation while induction of b-cells
proliferation occurs only under special conditions such as in new born
and pregnant and lactating animals or after 90% pancreatectomy.
PKCd has been found to be involved in a variety of cellular
events. Although several reports indicate a pro-apoptotic role,
PKCd was also shown to exert anti-apoptotic and proliferative
effects in various cell types. Such opposing effects of PKCd may be
cell type- or stimulus-specific or mediated by spatio-temporal
differences of PKCd activation. There is evidence that, similar to
p21
Cip1/WAF1, different functional effects of PKCd are connected
with the diverse compartmentalization of the enzyme. Upon
stimulation with phorbol ester or fatty acids, PKCd redistributes
between a cytosolic, a membrane-bound and a cytoskeleton-
associated compartment in b-cells [36]. The pro-apoptotic effect of
PKCd is linked to its nuclear accumulation [37,38]. Furthermore,
cleavage of PKCd by caspase-3 releases a constitutively active
fragment that promotes apoptosis [39]. Our data suggest that a
substantial amount of PKCdWT in transgenic cells is phosphor-
ylated at Ser643, an autophosphorylation site and, consequently, is
stimulated under control culture conditions. This increased
activity does not induce apoptotic cell death suggesting that
additional factors generated under stress conditions are needed to
turn PKCd into a pro-apoptotic kinase (Fig. 7). Reduced PKCd
activity significantly augmented apoptosis consistently in
PKCdKN INS-1E cells (up to 2-fold), in PKCdKN transgenic
mouse b-cells (by 60%), as well as after down regulation of PKCd
by RNA interference in control INS-1E cells (2-fold). Although not
discussed in detail, in a study by Cantley et al. using PKCdKO
mice, the rate of apoptosis was 80% higher in knockout cells than
in control cells [11]. The physiological impact of this finding
remains unclear, especially as islet size and insulin content were
not reduced in PKCdKO mice when compared to wild type mice
[40]. In agreement, mice that express PKCdKN exclusively in b-
cells show no reduction in islet size and insulin content [14,41].
In addition to cell cycle regulation, emerging evidence suggests
that p21
Cip1/WAF1 exerts other functions in diverse cellular
processes, including cell differentiation and survival. The impaired
replication and increased apoptosis of b-cells of p21
Cip1/WAF1
transgenic mice mirror our observations obtained in insulin
secreting cells with reduced PKCd activity and may thus result
from prolonged nuclear accumulation of p21
Cip1/WAF1 [29].
Interestingly, similar to PKCdKO mice, these mice show
improved recovery from streptozotocin-induced hyperglycemia,
which has been attributed to an increased regeneration of insulin-
producing cells [11,29]. In line, our previous study disclosed
protection of mice with b-cell specific expression of PKCdKN
against HFD-induced hyperglycemia. Apparent contradictory to
this assumption are two studies which link stress-induced
expression of p21
Cip1/WAF1 to reduced insulin mRNA and b-cell
failure. In one study oxidative stress-induced expression or
Figure 5. Effects of rottlerin and phorbol ester on cellular distribution of p21
Cip1/WAF1. Representative pictures of immunocytochemical
staining for p21
Cip1/WAF1 in INS-1E cells after 16 h serum starvation (control), after 90 min treatment with the PKCd inhibitor rottlerin (10 mM) and after
stimulation with PMA (1 mM for 2 min) in the presence or absence of the PKCd inhibitor rottlerin (10 mM) for 90 min.
doi:10.1371/journal.pone.0028828.g005
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Cip1/WAF1 in rat islets suppressed
insulin biogenesis [42]. In the second study using a mouse model
with deficient DNA repair reduced b-cell proliferation and the
onset of diabetes was accompanied by increased expression of
p21
Cip1/WAF1 [43]. One difference which might explain these
opposing results between the two latter studies and our cell models
Figure 6. Cells treated with siRNA against PKCd accumulate dephosphorylated p21
Cip1/WAF1 in nuclei and display increased
apoptosis. (A) Representative Western blots of PKCd, phospho-Ser146 p21
Cip1/WAF1 and p21
Cip1/WAF1 of control INS-1E cells and INS-1E cells treated
with control siRNA or PKCd-specific siRNA and the respective densitometric analysis presented as means + SEM of n=3 independent experiments.
*( p ,0.05) and ** (p,0.01) indicate significance to the respective band of control INS-1E cells set to 100%. (B) Percentage of p21
Cip1/WAF1 positive
nuclei analyzed by laser scanning microscopy is expressed as means + SEM of n=3–4 independent experiments. (C–E) Percentage of TUNEL positive
INS-1E cells treated with siRNA (C), control INS-1E cells, PKCdWT and PKCdKN INS-1E cells (D) and islet cells isolated from control mice, PKCdWT and
PKCdKN transgenic mice (E) expressed as means + SEM of n=3 independent experiments. * (p,0.05) indicates significance to the number of TUNEL-
positive control INS-1E cells.
doi:10.1371/journal.pone.0028828.g006
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Cip1/WAF1, while in our cell
systems endogenous p21
Cip1/WAF1 expression is transient.
Phosphorylation events presumably not only regulate the compart-
mentalization but also the protein stability of p21
Cip1/WAF,a l t h o u g h
controversial data have been reported on this issue. It was previously
shown that PKB-dependent phosphorylation of p21
Cip1/WAF1 at both
Thr145 and Ser146 increases the stability of the CDK inhibitor and
enhances its anti-apoptotic activity [31,44,45]. However, in our
experiments, inhibition of PKB by Akti-1/2 affected neither
phosphorylation nor nuclear accumulation of p21
Cip1/WAF1, suggest-
ing a minor role of PKB in our cell system. Likewise, inhibition of
ERK1/2 with PD98059 had no impact on the subcellular distribution
and phosphorylation of p21
Cip1/WAF1. Although we did not study the
effect of PKCd on p21
Cip1/WAF1 stability in detail, PKCdWT cells
revealed a significantly lower amount of p21
Cip1/WAF1 than control or
PKCdKN cells, suggesting that Ser146 phosphorylation affects
p21
Cip1/WAF1 stability. These data are consistent with reports
demonstrating that phosphorylation of p21
Cip1/WAF1 at Ser146 by
PKCd leads to destabilization of the CDK inhibitor [46].
Thus, our data indicate that p21
Cip1/WAF1 exerts a dual effect
depending on its subcellular distribution (Fig. 7). When trapped in
the cytosol due to phosphorylation, p21
Cip1/WAF1 might favor
proliferation, a notion supported by the increased Ki67 staining in
PKCdWT cells. This cytosolic localization of p21
Cip1/WAF1 is
known to exert anti-apoptotic effects by CDK-dependent or
independent mechanisms [47,48]. One mechanism of anti-
apoptotic action of p21
Cip1/WAF1 involves its direct binding to
and inhibition of the pro-apoptotic kinases ASK1 or JNK
[31,49,50].
In contrast, nuclear p21
Cip1/WAF1 inhibits cell cycle progression
and might eventually lead to apoptosis. In addition to the binding
to cyclin-CDK complexes, p21
Cip1/WAF1 interacts directly with the
proliferating cell nuclear antigen (PCNA), and thereby inhibits
PCNA-dependent DNA replication [51]. Improper and prolonged
nuclear accumulation of p21
Cip1/WAF1 may explain the observa-
tions that mice overexpressing p21
Cip1/WAF1 specifically in b-cells
develop age-related hyperglycemia under normal feeding [29].
Whether PKCd-dependent regulation of p21
Cip1/WAF1 affects
b-cell function in humans needs further experimental evidence.
The expression of p21
Cip1/WAF1 in human islets and the fact that
PKCd reduces nuclear accumulation of p21
Cip1/WAF1 in primary
mouse islet cells supports the view that the cell cycle inhibitor
could play a regulatory role also in adult human b-cells under
special proliferative conditions [23].
In conclusion, our study demonstrates that PKCd induces
posttranslational modifications of p21
Cip1/WAF1 which, in turn,
determine its subcellular distribution and function in INS-1E cells.
This study reveals that PKCd is not per se a pro-apoptotic kinase
and underlines the importance of understanding molecular
mechanisms for the evaluation of therapeutic targets in the
treatment of diabetes mellitus.
Materials and Methods
Ethics Statement
The use for scientific purposes of isolated human islets was
approved by the local ethics committee (University of Tuebingen,
Medical Faculty No. 533/2010BO2). All animal experiments were
done in accordance with the accepted standard of human care of
animals and approved by the local Animal Care and Use
Committee (Notification from 12.01.10).
Cell preparations, culture and transfection
INS-1E cells, kindly provided by C. B. Wollheim (University of
Geneva, Switzerland), were cultured in RPMI 1640 (GIBCO)
containing 11 mM glucose, 2 mM L-glutamine, 10 mM HEPES,
1 mM sodium pyruvate, 0.05 mM b-mercaptoethanol and 10%
FCS as described [52]. INS-1E cells were stably transduced with
retroviruses encoding wild type PKCd (PKCdWT) or the K376R-
mutation in the ATP-binding domain (PKCdKN) driven by the
rat insulin 1 gene promoter. Cell clones expressing the transgene
were selected by geneticin (G418) and subcloned as single cell
clones. INS-1E cells were transfected with siRNA against PKCd
(20 nM/5610
5 cells; On-Target plus siRNA, # J-080142-05,
Dharmacon, Chicago) using a siRNA transfection reagent
(DharmaFECT 3, Dharmacon). As control, siRNA against
luciferase (20 nM/5610
5 cells) was transfected in parallel. Cells
were used 2 d after transfection. p21
Cip1/WAF1-proficient and
deficient mouse embryonic fibroblasts (MEFs) were cultured in
DMEM supplemented with 10% FCS and antibiotics.
Figure 7. Dual effect of PKCd in insulin-secreting cells. PKCd supports proliferation by phosphorylation of p21
Cip/WAF1 which results in nuclear
extrusion of the cell cycle inhibitor (white symbols). In the presence of metabolic stress, e.g. prolonged exposure to high concentrations of free fatty
acids (FFA) PKCd favors apoptotic cell death through nuclear accumulation and stimulation of FOXO1 (gray symbols). PKCdKN (white and gray stripes)
inhibits both the anti-apoptotic and pro-apoptotic effect of PKCd.
doi:10.1371/journal.pone.0028828.g007
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(European Consortium of Islet Transplantation) Center in Geneva
(Switzerland). Human islets, purified by hand picking, were
digested to single cells with trypsin (40 units/ml trypsin-EDTA
in PBS) for 4–6 min at 37uC. Isolated islet cells were then cultured
in CMRL 1066 medium (GIBCO, Invitrogen GmbH, Karlsruhe,
Germany) containing 5.5 mM glucose, 10% fetal calf serum (FCS,
Biochrom, Berlin, Germany), 2 mM L-glutamine and 10 mM
HEPES. After 2 d culture on collagen (2 mg/ml human collagen
type 1) coated glass cover slips cells were used for immunocyto-
chemical staining. Transgenic mice were generated and isolated
islet cell culture was prepared as described previously [14,53].
Cell cycle analysis by Nicoletti
After 2 d culture, cells were detached by trypsin and
resuspended in Nicoletti buffer containing 0.1% sodium citrate,
pH 7.4, 0.1% Triton X-100 and 50 mg/ml propidium iodide.
DNA staining was analyzed by flow cytometry using the FL2-H
channel.
Immunocytochemistry and TUNEL staining
Isolated mouse islet cells, INS-1E cells and MEFs were cultured
for 2 d on L-poly-ornithine (0.001%) coated glass cover slips. Cells
were fixed with 4% paraformaldehyde in phosphate-buffered
saline (PBS), permeabilized with 0.2% Triton X-100 and
preincubated in 10% FCS-PBS for 45 min. Primary antibodies
against phospho-Ser10 histone H3 (1:150, from Millipore,
Billerica, MA), p21
Cip1/WAF1 (rabbit polyclonal antibody, 1:200,
from Santa Cruz Biotechnology, Santa Cruz, CA or mouse
monoclonal antibody, 1:150, from Becton Dickinson, Heidelberg,
Germany), Ki67 (1:50, DakoCytomation, Hamburg, Germany)
were applied overnight in 10% FCS-PBS. After 30 min washing
with FCS-PBS the cells were incubated for 1 h with the secondary
antibody in 10% FBS-PBS (Alexa-Fluor488 coupled anti-rabbit or
anti-mouse IgG, 1:400, Invitrogen GmbH, Darmstadt, Germany).
Thereafter, nuclei were stained with 1 mM TOPRO-3 (Invitrogen)
in PBS for 1 h. The fluorescence was examined with a confocal
laser scanning microscope (Leica, Wetzlar, Germany). For
TUNEL staining cells were prepared according to the protocol
provided by the commercial kit (Roche Diagnostics, Mannheim,
Germany).
Western blotting
Islets and INS-1E cells were lysed in buffer containing 125 mM
NaCl, 1% Triton X-100, 0.1% SDS, 10 mM EDTA, 25 mM
HEPES pH 7.3, 10 mM NaPP, 10 mM NaF, 1 mM Na-vanadate,
10 mg/ml pepstatin A, 10 mg/ml aprotinin and 0.1 mM PMSF.
Protein concentrations of cell lysates were determined using the
Bradford dye-binding procedure from Biorad Laboratories (Munich,
Germany). Cytosolic and nuclear fractions of INS-1E cells were
prepared using a commercial kit (Pierce Biotechnology, RockfordIL).
Cellhomogenates or cytosolic and nuclear fractions were subjected to
SDS-PAGE (8–12%) and blotted onto nitrocellulose membranes
(Schleicher & Schuell, Dassel, Germany). Membranes were incubat-
ed overnight with primary antibodies (diluted 1:1000 in TBS-Tween
containing 5% BSA or 5% milk powder) followed by incubation with
horseradish peroxidase-coupled anti-rabbit IgG (1:2000 in TBS-
Tween, 5% milk powder). Antibodies against PKCd, phospho-
Thr505 and phospho-Ser643 PKCd, p27 and tubulin were from Cell
Signaling Technology (Danvers, MA), antibodies against GAPDH,
histone H1, and polyclonal antibodies against p21
Cip1/WAF1 and
phospho-p21
Cip1/WAF1 (phospho-Ser146, phospho-Thr145) were
from Santa Cruz Biotechnology.
Statistics
Data are expressed as means 6 SEM, p,0.05 (unpaired
Student’s t-test or 2-way ANOVA followed by Bonferroni post test
where applicable) was considered significant.
Supporting Information
Figure S1 Specificity controls of the p21
Cip1/WAF1 anti-
bodies. (A) Shown is a Western blot of homogenates from
p21
Cip1/WAF1 proficient or deficient MEFs that were either left
untreated or incubated with the DNA-damaging agent bleomycin
(BLM, 10 mM for 20 h). On Western blots p21
Cip1/WAF1 migrates
at an apparent molecular weight of 17–18 kD. Tubulin was used
as loading control. (B) Immunocytochemical staining of
p21
Cip1/WAF1 in p21
Cip1/WAF1-proficient and deficient MEFs
cultured under control conditions (con) or in the presence of
bleomycin (BLM) using antibodies from Santa Cruz (left pictures)
or Becton Dickinson (BD, right pictures).
(TIF)
Figure S2 Cell cycle dependent expression of p21
Cip1/WAF1.
Shown are representative pictures of immunocytochemical
staining for p21
Cip1/WAF1 (A) 16 h after serum deprivation and
(B) 32 h after re-addition of 10% serum in control, PKCdWT and
PKCdKN INS-1E cells. Nuclei are stained in red, p21
Cip/WAF1 in
green. Note the absence of nuclear staining of p21
Cip/WAF1 in
PKCdWT INS-1E cells 32 h after re-addition of 10% serum.
(TIF)
Figure S3 Phosphorylation and nuclear extrusion of
p21
Cip1/WAF1 is not mediated by PKB/Akt or ERK1/2. (A)
Western blot analysis representative for 3 independent experi-
ments with PKCdWT cell homogenates for the status of Ser146
p21
Cip1/WAF1 phosphorylation. Cells were cultured for the
indicated time in the presence of the protein kinase B inhibitor
Akti-1/2 (Akti, 5 mM) or PD98059 (PD, 10 mM), a specific
inhibitor of the ERK upstream MEK kinases. (B) Immunocyto-
chemical staining for p21
Cip1/WAF1 (green) in PKCdWT cells that
were either left untreated or incubated for 24 h in the presence of
Akti-1/2 (5 mM) or PD98059 (10 mM). Nuclei are stained in red.
Both inhibitors (Akti and PD98059) were effective even after
prolonged cell culture. Thus, IGF-1-induced PKB phosphoryla-
tion was inhibited in the cells treated with Akti. Phorbol ester-
induced phosphorylation of ERK and c-fos induction were
inhibited in the cells treated with PD98059 (data not shown).
(TIF)
Figure S4 Changes in cell cycle progression of INS-1E
cell expressing PKCdKN. Representative pictures of immuno-
cytochemical staining for phospho-Ser10 histone H3. Nuclei are
stained in red, phospho-Ser10 histone H3 in green. The
percentage of positive cells is given as means 6 SEM from 3–4
independent experiments. * (p,0.05) represents significance to
control INS-1E cells.
(TIF)
Figure S5 Cell cycle analysis of INS-1E cells. Represen-
tative FACS measurements of propidium iodide-stained nuclear
DNA from control INS-1E, PKCdWT and PKCdKN cells (A)
after standard culture and (B) after treatment with colchicine
(0.5 mM for 2 d) Results show means + SEM from n=3–4
independent experiments. * (p,0.05) and ** (p,0.01) represent
significance to the respective cell cycle phase of control INS-1E
cells; ## (p,0.01) represents significance to the respective
condition without colchicine treatment.
(TIF)
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cells. Representative FACS measurements of propidium iodide-
stained nuclear DNA from islet cells isolated of (A) wild type mice
and (B) PKCdKN transgenic mice and means + SEM from n=3
independent experiments.
(TIF)
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